Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Kiniksa reports final data from first-in-human trial of KPL-404

May 5, 2021

Revolo presents encouraging safety data for its peptide drug for allergic disease

May 5, 2021

Vaxart reports phase I findings on oral COVID-19 vaccine VXA-CoV2-1

May 4, 2021

Novavax announces pediatric expansion of pivotal PREVENT-19 trial of NVX-CoV-2373

May 4, 2021

Adrenaline release immobilizes immune cell responses

May 3, 2021

MiR-17-92 as a therapeutic target in lupus nephritis and other autoimmune diseases

April 30, 2021

Xencor initiates phase I study of XmAb-564 for autoimmune diseases

April 30, 2021

SciClone evaluates COVID-19 inactivated vaccine with Zadaxin in China

April 27, 2021

Phase III MELODY study of nirsevimab to prevent RSV infection in infants meets primary endpoint

April 26, 2021

Alladapt initiates phase I/II Harmony Study of ADP-101

April 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...